Stage
Seed, Series A, Series B, Growth
Stated focus: France, Belgium, Netherlands, United States · 3 verticals
A Lyon based life sciences investor backing Amyl Therapeutics through its Series A extension, financing seed through growth stage BioTech and healthcare companies across Europe.